Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$861M |
| 2 |
Eli Lilly
LLY
|
+$711M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$611M |
| 4 |
Ford
F
|
+$490M |
| 5 |
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
|
+$405M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ELN
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
|
+$504M |
| 2 |
DELL
DELL INC
DELL
|
+$374M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$369M |
| 4 |
Pfizer
PFE
|
+$357M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.21% |
| 2 | Financials | 13.26% |
| 3 | Energy | 12.32% |
| 4 | Technology | 10.55% |
| 5 | Industrials | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Merck
MRK
$322B
| $4.09B | 2% |
85,628,927
-6,202,810
| -7% | -$284M |
|
2
JPMorgan Chase
JPM
$930B
| $3.14B | 1.53% |
53,627,602
+714,481
| +1% | +$39.1M |
|
3
Microsoft
MSFT
$2.83T
| $2.91B | 1.42% |
77,803,743
-1,089,049
| -1% | -$39.6M |
|
4
Apple
AAPL
$4.72T
| $2.62B | 1.28% |
130,597,040
-422,016
| -0.3% | -$7.97M |
|
|
5
Pfizer
PFE
$143B
| $2.51B | 1.23% |
86,395,708
-12,275,667
| -12% | -$357M |
|
6
Medtronic
MDT
$105B
| $2.5B | 1.22% |
43,498,867
-427,867
| -1% | -$24.3M |
|
|
RDS.A
7
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $2.39B | 1.17% |
33,531,772
-57,465
| -0.2% | -$3.86M |
|
8
Chevron
CVX
$387B
| $2.34B | 1.14% |
18,742,899
-127,315
| -0.7% | -$15.4M |
|
9
Wells Fargo
WFC
$261B
| $2.32B | 1.14% |
51,206,163
-95,764
| -0.2% | -$4.14M |
|
10
Cisco
CSCO
$444B
| $2.12B | 1.04% |
94,622,323
+14,476,561
| +18% | +$320M |
|
11
GE Aerospace
GE
$362B
| $1.9B | 0.93% |
14,133,775
-1,833,077
| -11% | -$231M |
|
|
BHI
12
DELISTED
Baker Hughes
BHI
| $1.83B | 0.89% |
33,082,826
+520,965
| +2% | +$28.5M |
|
13
BP
BP
$113B
| $1.82B | 0.89% |
45,843,328
-3,683
| -0% | -$137K |
|
14
Citigroup
C
$221B
| $1.76B | 0.86% |
33,734,062
-80,947
| -0.2% | -$4.1M |
|
15
Johnson & Johnson
JNJ
$624B
| $1.74B | 0.85% |
18,960,187
-224,921
| -1% | -$20.7M |
|
|
16
Teva Pharmaceuticals
TEVA
$36.3B
| $1.73B | 0.84% |
43,093,486
+21,877,679
| +103% | +$861M |
|
17
ExxonMobil
XOM
$650B
| $1.71B | 0.84% |
16,907,601
+2,801,243
| +20% | +$259M |
|
18
DuPont de Nemours
DD
$18.6B
| $1.65B | 0.8% |
14,634,730
+21,673
| +0.1% | +$2.22M |
|
19
CVS Health
CVS
$136B
| $1.62B | 0.79% |
22,603,137
-3,374,299
| -13% | -$217M |
|
20
Exelon
EXC
$48.4B
| $1.56B | 0.76% |
79,979,321
+448,804
| +0.6% | +$9.03M |
|
21
American International
AIG
$41.4B
| $1.55B | 0.76% |
30,278,599
+298,881
| +1% | +$14.9M |
|
22
Duke Energy
DUK
$101B
| $1.52B | 0.74% |
21,954,655
+470,592
| +2% | +$32.9M |
|
23
Freeport-McMoran
FCX
$91.3B
| $1.47B | 0.72% |
39,061,847
+4,581,950
| +13% | +$162M |
|
|
TLM
24
DELISTED
TALISMAN ENERGY INC
TLM
| $1.4B | 0.69% |
120,544,726
+29,175,661
| +32% | +$351M |
|
25
Intel
INTC
$504B
| $1.39B | 0.68% |
53,356,294
+2,634,365
| +5% | +$63.7M |
|
Similar funds
Franklin Resources's Q4 2013 Portfolio in Review
As of Q4 2013, Franklin Resources held 1,570 positions worth $205B, up 8.9% from $188B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Franklin Resources's Q4 2013 filing shows 104 new, 491 increased, 638 reduced and 72 closed positions. Its largest new stake was Paramount Global Class B: 10,381,550 shares worth $662M. The largest sale was ELAN CORP ADS(RP1 ORD4IRISH PN, an estimated $504M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 15% a quarter earlier, followed by Financials and Energy.
- Franklin Resources's largest Q4 2013 buy was Paramount Global Class B: 10,381,550 shares worth $662M.
- Franklin Resources added most to Teva Pharmaceuticals in Q4 2013, an estimated $861M increase.
- Franklin Resources's biggest Q4 2013 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $369M.
- Franklin Resources fully exited ELAN CORP ADS(RP1 ORD4IRISH PN in Q4 2013, selling an estimated $504M.
- Franklin Resources's ten largest holdings make up 13% of its $205B portfolio in Q4 2013.
- Franklin Resources opened 104 new positions and closed 72 in Q4 2013.
- Franklin Resources's portfolio value rose 8.9% quarter-over-quarter to $205B.
Based on Franklin Resources's 13F filing for Q4 2013, filed 12 Feb 2014.